Publications by authors named "Gary Pestano"

Claim this Profile
F
Functional Characterization and a Real-World Clinical Laboratory Pilot of the Foundation for the National Institutes of Health Circulating Tumor DNA Quality Control Materials.
Cloud P Paweletz, Thomas D Forbes, Laura Yee, Grace Heavey, Hua-Jun He, Gary A Pestano

JCO Precis Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 mRNA vaccine immune response to the addition of osteopathic manipulative treatment with lymphatic pumps: a randomized controlled trial.
Eric S Martinez, Sebastien Fuchs, Hendrik Szurmant, Xunxuan Chen, Andrew Comer, Gary Pestano

Virus Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ctDNA Clearance as an Early Indicator of Improved Clinical Outcomes in Advanced NSCLC Treated with TKI: Findings from an Aggregate Analysis of Eight Clinical Trials.
Hillary S Andrews, Nevine Zariffa, Katherine K Nishimura, Stephanie H Choi, Shibing Deng, Gary A Pestano

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a Novel Whole Blood Separation and Transport Device for Targeted and Untargeted Proteomics.
Colin T McDowell, Amanda L Weaver, Nylev Vargas-Cruz, Nathan K Kaiser, Charles M Nichols, Gary A Pestano

Biomedicines· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages.
Brittany A McKelvey, Hillary S Andrews, Frederick L Baehner, James Chen, Carin R Espenschied, Gary A Pestano

Diagnostics (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and translational biology of the blood-based VeriStrat® proteomic test used in cancer immunotherapy treatment guidance.
Matthew A Koc, Timothy Aaron Wiles, Daniel C Weinhold, Steven Rightmyer, Amanda L Weaver, Gary A Pestano

J Mass Spectrom Adv Clin Lab· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Coronavirus Standards Working Group's roadmap for improved population testing.
Tim Mercer, Neil Almond, Michael A Crone, Patrick S G Chain, Alina Deshpande, Gary A Pestano

Nat Biotechnol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of antibody response durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 vaccines in healthcare workers.
Wendy M Brunner, Daniel Freilich, Jennifer Victory, Nicole Krupa, Melissa B Scribani, Gary A Pestano

Int J Infect Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonization of Multiple SARS-CoV-2 Reference Materials Using the WHO IS (NIBSC 20/136): Results and Implications.
William Jonathan Windsor, Yannik Roell, Heidi Tucker, Chi-An Cheng, Sara Suliman, Gary A Pestano

Front Microbiol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytic and Clinical Validation of a Pan-Cancer NGS Liquid Biopsy Test for the Detection of Copy Number Amplifications, Fusions and Exon Skipping Variants.
Audrey Audetat, Chérie Tschida, Sarah Kreston, Adam Stephen, Brittany D'Alessio, Gary A Pestano

Diagnostics (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Next-Generation Sequencing of Liquid Biopsy Samples from Patients with NSCLC.
Hestia Mellert, Jordan Reese, Leisa Jackson, Victoria Maxwell, Chérie Tschida, Gary A Pestano

Diagnostics (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Characterization of a Novel Blood Collection and Transportation Device for Proteomic Applications.
Nathan K Kaiser, Maximillian Steers, Charles M Nichols, Hestia Mellert, Gary A Pestano

Diagnostics (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a TCR beta repertoire assay for profiling liquid biopsies from NSCLC donors.
Leisa P Jackson, Benjamin A Tjoa, Hestia Mellert, Gary A Pestano

Cancer Drug Resist· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal monitoring for the emergence of epidermal growth factor C797S resistance mutations in non-small cell lung cancer using blood-based droplet digital PCR.
Mark Bowling, Hyder Arastu, Victoria Edwards, Leisa Jackson, Scott Thurston, Gary Pestano

Cancer Drug Resist· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction.
Hestia S Mellert, Kristin E Alexander, Leisa P Jackson, Gary A Pestano

J Vis Exp· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Clinical Utility of a Blood-Based Test Service for the Rapid Identification of Actionable Mutations in Non-Small Cell Lung Carcinoma.
Hestia Mellert, Trudi Foreman, Leisa Jackson, Dianna Maar, Scott Thurston, Gary A Pestano

J Mol Diagn· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance.
Howard M Stern, Humphrey Gardner, Tomasz Burzykowski, Wafaa Elatre, Carol O'Brien, Gary A Pestano

Clin Cancer Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERG overexpression and PTEN status predict capsular penetration in prostate carcinoma.
Raymond B Nagle, Amit M Algotar, Connie C Cortez, Katherine Smith, Carol Jones, Gary Pestano

Prostate· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma.
Ritu Bhalla, Lakshmi P Kunju, Scott A Tomlins, Kelly Christopherson, Connie Cortez, Gary A Pestano

Mod Pathol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing mutual exclusivity of ETS rearranged prostate cancer.
Maria A Svensson, Christopher J LaFargue, Theresa Y MacDonald, Dorothee Pflueger, Naoki Kitabayashi, Gary A Pestano

Lab Invest· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-based detection of ERG rearrangement-positive prostate cancer.
Kyung Park, Scott A Tomlins, Kumaran M Mudaliar, Ya-Lin Chiu, Raquel Esgueva, Gary Pestano

Neoplasia· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Cell Surface Receptors as Molecular Imaging Candidates for Metastatic Prostate Cancer.
Isis C Sroka, Gerald D Pond, Raymond B Nagle, Frank Porreca, Tamara King, Gary Pestano

Open Prost Cancer J· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteopontin-c is a selective marker of breast cancer.
Mana Mirza, Elizabeth Shaughnessy, John K Hurley, Kristie A Vanpatten, Gary A Pestano

Int J Cancer· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers.
Marta Guix, Nara de Matos Granja, Ingrid Meszoely, Theresa B Adkins, Bobbye M Wieman, Gary Pestano

J Clin Oncol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of mTOR signaling pathway markers in prostate cancer progression.
Celeste L Kremer, Rob R Klein, Jenny Mendelson, Walden Browne, Linda K Samadzedeh, Gary A Pestano

Prostate· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis